Examining mechanisms of protein complex at a basic cell biological level
A new study highlighting the importance of a large protein complex called the exocyst in cell growth, division and communication reveals new functions and mechanisms that are essential to how molecules move across a membrane through vesicles in a cell.
Understanding how these mechanisms work in normal cells at the basic biological level will inform future research into how those functions are disrupted in developmental and neurological disorders.
“It’s the first time a role for membrane fusion has been described for this complex and it’s a breakthrough in how we think about the way the exocyst complex works,” said Mary Munson, professor and vice chair for diversity in the Department of Biochemistry & Molecular Biotechnology, associate vice provost for equity in science in the Office of Health Equity and a co-corresponding author on the study published in Nature Structural & Molecular Biology. The research was done in collaboration with Tae-Young Yoon, professor of biological sciences at the School of Biological Sciences and Institute for Molecular Biology and Genetics at Seoul National University in Seoul, South Korea.
“Until our collaborative study, exocyst was understood to recognize and possibly tether secretory vesicles to the cell membrane, prior to exocytosis. In this study, we reveal biophysical studies that indicate exocyst playing several critical roles that directly facilitate fusion of the vesicles with the cell membrane to drive cargo delivery,” Munson said.
Robust control of exocytosis is critical for all cells to grow, divide and communicate properly. Dysfunction of exocyst regulation has been linked to many physiological problems in different organisms.
“It’s really an exciting development in our field, as the exocyst complex had not previously been shown to directly control vesicle fusion,” Munson said. “The complex recognizes the right vessel, the right place on the cell surface and the right time for the cargo to be delivered. It does that by talking to the membrane fusion protein.”
In 2023, Munson received a National Institutes of Health award for $3.3 million over five years to support this research.
Munson was recently named a 2024 recipient of a Zenith Award from the Association for Women in Science. The award honors senior career professionals with a lifetime of innovative achievements in STEM and a commitment to workplace diversity.
This article is republished from the UMass Chan Medical School News. Read the original here.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Building a better model for drug delivery across the blood–brain barrier
Industry and academic scientists collaborated to develop a rat with humanized iron-transport receptors, enabling research into iron homeostasis and drugs that cross the brain’s barrier.

Fat synthesis enzyme crucial for milk fat and newborn growth
Researchers found that a deficiency of the fatty acid synthesis enzyme stearoyl-CoA desaturase-1 reduced mammary gland function during lactation and caused low birth weight in newborns that were fed milk from enzyme-deficient glands.

Flipping lipids and slime molds
A dull first job nearly pushed JBC associate editor Todd Graham out of science. Then a slime mold project changed his path. Now, he studies membrane biology and reflects on discovery, persistence and mentoring through uncertainty.

How smelling death alters worm behavior
Researchers have found that the roundworm C. elegans can smell death, and it changes how the worms behave, reproduce and age.

A chance encounter with the lab
Payton Stevens never planned to become a pancreatic cancer researcher. A temporary job set him on a path from rural Kentucky to leading research on Wnt signaling and metastasis, where he now pairs discovery with mentorship and science advocacy.

Light-activated small molecule could transform eye infection treatment
Contact lenses raise the risk of infectious keratitis, a leading cause of blindness worldwide. A biotech company is commercializing a light-activated therapy using a ROS-generating molecule to rapidly kill microbes in the cornea to preserve vision.